Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0920646 (
renal ischemia
)
2,515
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Renal ischemia
as well as oxygen metabolites play an important role in renal injury during myoglobinuric acute renal failure (ARF). On the other hand, flavonoids, a diverse group of constituents naturally occurring in plants, have a strong antioxidative activity, and have been implicated in vascular relaxation. In this study the protective effect of a new bioflavonoid proanthocyanidin-
BP1
(
BP1
), extracted from seeds of grapes, was evaluated in glycerol-induced ARF in rats. Stereological methods were used to quantify changes in renal morphology associated with ARF. Volume density of tubular lumen and intratubular cast formations, nuclear parameters (area, diameter, volume) of epithelial cells in the cortical proximal tubules, and glomerular parameters (surface area, diameter, volume, perimeter) were estimated on kidney sections of rats treated either with 50% glycerol (8 mL/kg i.m.) alone.
BP1
(20 mg/kg i.p.) in addition to glycerol, or
BP1
alone. It was noted that the volume density of tubular lumen and cast formations were significantly lower (p < 0.001) in kidneys of the rats treated with
BP1
in addition to glycerol, compared with those treated with glycerol alone. There were no significant differences in glomerular and nuclear parameters between glycerol treated, and
BP1
in addition to glycerol treated rats. Renal function was significantly improved in rats treated with
BP1
in addition to glycerol. The results suggest that
BP1
is a protective agent in glycerol model of ARF. This effect is probably due to the antioxidative activity of
BP1
and reduced toxicity of myoglobin in renal tissue. Moreover, it is possible that the ability of
BP1
to protect the kidney is dependent upon renal vascular relaxation. The potential beneficial effects of bioflavonoid-
BP1
demonstrated in experimental ARF could be considered in therapy of myoglobinuric ARF.
...
PMID:Protective effect of a bioflavonoid proanthocyanidin-BP1 in glycerol-induced acute renal failure in the rat: renal stereological study. 1058 25